2666 — Genertec Universal Medical Co Balance Sheet
0.000.00%
- HK$9.29bn
- HK$66.40bn
- CNY13.66bn
- 38
- 91
- 84
- 85
Annual balance sheet for Genertec Universal Medical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,037 | 2,396 | 2,855 | 2,906 | 2,381 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 18,863 | 21,049 | 23,997 | 26,245 | 28,506 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 21,833 | 25,042 | 28,161 | 30,695 | 33,075 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3,110 | 3,334 | 4,975 | 5,553 | 7,627 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 61,511 | 69,966 | 76,980 | 80,345 | 86,032 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 23,320 | 18,791 | 26,462 | 30,073 | 28,618 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 49,088 | 55,201 | 61,340 | 62,995 | 67,179 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 12,423 | 14,765 | 15,641 | 17,350 | 18,854 |
Total Liabilities & Shareholders' Equity | 61,511 | 69,966 | 76,980 | 80,345 | 86,032 |
Total Common Shares Outstanding |